about
Transcription of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase type 3 gene, ATP2A3, is regulated by the calcineurin/NFAT pathway in endothelial cellsErythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytesGlutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities.Delayed cardiomyopathy in dystrophin deficient mdx mice relies on intrinsic glutathione resource.The cardiac beta2-adrenergic signalling a new role for the cPLA2.Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling.Inhibition of the calcium pump by human parathyroid hormone-(1-34) and human calcitonin in liver plasma membranesEmergence of Orai3 activity during cardiac hypertrophy.N-acetylcysteine prevents the deleterious effect of tumor necrosis factor-(alpha) on calcium transients and contraction in adult rat cardiomyocytes.Glucagon-(19-29) exerts a biphasic action on the liver plasma membrane Ca2+ pump which is mediated by G proteins.The inhibitor of liver plasma membrane (Ca2+-Mg2+)-ATPase. Purification and identification as a mediator of glucagon action.M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.Inhibition by glucagon of the cGMP-inhibited low-Km cAMP phosphodiesterase in heart is mediated by a pertussis toxin-sensitive G-protein.Arachidonic acid mediates dual effect of TNF-alpha on Ca2+ transients and contraction of adult rat cardiomyocytes.beta2-Adrenergic signaling in human heart: shift from the cyclic AMP to the arachidonic acid pathway.The cytosolic phospholipase A2 pathway, a safeguard of beta2-adrenergic cardiac effects in rat.TNFR1 and TNFR2 signaling interplay in cardiac myocytes.M2 kupffer cells promote hepatocyte senescence: an IL-6-dependent protective mechanism against alcoholic liver disease.The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy.Synergistic actions of glucagon and miniglucagon on Ca2+ mobilization in cardiac cells.Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesteraseA glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagonAdult cardiac myocytes survive and remain excitable during long-term culture on synthetic supportsCardiac inflammatory CD11b/c cells exert a protective role in hypertrophied cardiomyocyte by promoting TNFR- and Orai3- dependent signalingMiniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagon[Calcium and cell death]Activation of Na+/Ca2+ exchange by adenosine in ewe heart sarcolemma is mediated by a pertussis toxin-sensitive G proteinGlucagon-(19-29), a Ca2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidase[Glucagon is processed to the (19-29) fragment at the level of the hepatocyte membrane][Hepatic cytoprotection (5). Calcium and hepatotoxicity]The high affinity (Ca2+-Mg2+)-ATPase in liver plasma membranes is a Ca2+ pump. Reconstitution of the purified enzyme into phospholipid vesiclesRegulation of liver plasma membrane Ca2+ pump[Calcium signal and contraction]Inhibition of the sarcolemmal Ca2+ pump in embryonic chick heart cells by mini-glucagonArachidonic acid drives mini-glucagon action in cardiac cellsXanthine affects [Ca2+]i and contractile responses of ventricular cardiocytes to electrical stimulation[A new look at the mechanism of action of glucagon]Evidence for a beta2-adrenergic/arachidonic acid pathway in ventricular cardiomyocytes. Regulation by the beta1-adrenergic/camp pathwayBiological effects of C-type natriuretic peptide in human myofibroblastic hepatic stellate cellsNeutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats
P50
Q24541510-6E217EA4-589B-4E3F-A465-76D766FAA152Q28294277-E8AF7B19-3509-42FD-855B-5C4919591593Q33421711-8220E5F2-5B2E-45A0-BF91-10071A2D4887Q34086953-6E65A5ED-E969-4C45-8A56-8EE1BBA76092Q35923025-E1E299BB-B241-4C35-8E1B-2E676A68494FQ36791996-6A6599D9-CC28-4446-B8A3-4D0B4B4FCF10Q41948101-7B7D41FB-A7DB-4AD4-BB0C-E0E3D54A8458Q42135344-1290DF2C-3F6D-4F6B-9898-AF084F8E7EDFQ42455817-7F93F660-92AA-4E9F-8DF4-BC9945999D75Q42478873-FC37199A-01F9-4F4C-ADCF-8D0D805C1B8EQ42513636-5B41F802-F5E1-4BE6-A9DD-2B23575111BBQ42710363-D4A67766-AE06-47AA-9ECD-BC6FE8B17EF1Q43550479-FFE97E96-E7A7-4361-9AFA-CD4756EA702BQ43984437-C135929B-B512-44B6-86FA-4292A2F852AAQ44628557-95399F05-B2DB-4232-8F9D-279BF52CC46FQ45280940-5B18048E-4D1C-43CB-BA2B-C64C48A63E00Q46968897-58258281-B958-4E63-A486-D9FDD9BF80C9Q51743027-6012936B-11D6-45F8-88E5-63960817E341Q51796834-70E93788-AE52-485F-87F0-02D000D1E7BCQ54154223-6782C0E6-8800-4798-879C-C10B8115700EQ59053515-31ED8DB6-5037-40E5-A2DA-CB4A4B223D1EQ59095575-E6DFC147-9A8B-4E7C-A1D8-E20A9E93FFC8Q59248685-DBA2369F-6674-48C2-AE01-6B34B567CB64Q64115717-4F24AD55-E0D2-49F9-ACBA-8301AE4E633FQ67916558-46D8592C-8A81-4B2F-BC4A-D18652698DC0Q68171377-F4EAF4FB-D1E0-413B-B3E9-0A25ED2916DAQ68358925-40CA55EA-E3BE-4C87-AB10-6827A2EDDE9CQ68434483-A5D5F742-428E-4D57-9A89-1B733E76FD68Q69204699-A1D44AB7-34EA-4D79-99B2-0E2C3664B679Q69549922-DE55737C-FD76-4B3B-8556-1324A716ECBEQ70026010-C03FA79A-78B0-4500-A786-3A37FD7F8D14Q70067664-FB684216-D74C-43A8-8D1D-51D6723E3E71Q71681220-CE9761C7-3BFD-46E2-A0A7-6574CA2D220AQ71806228-D73BE05E-EB3B-4B97-B5D9-00C667234659Q73316386-ED69084A-D991-4FDE-8626-5B11452413BBQ73745900-9F227FA4-B679-4426-BDE8-C598B3DF3A59Q77416570-855275CF-AF91-4C89-9F1E-7C20E5F5B526Q77747818-88CC0B9D-FEAF-4069-90D1-D2723758ACE4Q78122200-69BE0E83-E713-466F-A081-54C83B902447Q80814295-7E813D07-821A-4482-88DF-257613724CF7
P50
description
researcher ORCID ID = 0000-0002-0598-5545
@en
wetenschapper
@nl
name
Catherine Pavoine
@ast
Catherine Pavoine
@en
Catherine Pavoine
@es
Catherine Pavoine
@nl
type
label
Catherine Pavoine
@ast
Catherine Pavoine
@en
Catherine Pavoine
@es
Catherine Pavoine
@nl
prefLabel
Catherine Pavoine
@ast
Catherine Pavoine
@en
Catherine Pavoine
@es
Catherine Pavoine
@nl
P21
P31
P496
0000-0002-0598-5545